Cerezyme® is an enzyme replacement therapy (ERT), that treats pediatric and adult patients with Gaucher disease Type 1. Learn about Cerezyme® diagnosis, dosing, safety and support resources.

Welcome to the official HCP site for Cerezyme®, an enzyme replacement therapy (ERT), that treats pediatric and adult patients with Gaucher disease Type 1. Get access to support and resources for your patients. See full Prescribing Information, including Patient Medication Guide.

Initiate CEREZYME in a healthcare setting with appropriate medical monitoring and support measures, including access to cardiopulmonary resuscitation equipment.

2024年9月18日 · 伊米苷酶 (Cerezyme)用于确诊患有导致下列1种或多种病症的I型戈谢氏病 (葡萄糖脑苷脂沉积病)的儿童及成人患者的长期酶替代疗法：贫血、血小板减少、骨病、肝肿大或脾肿大。

注射用伊米苷酶说明书 请仔细阅读说明书并在医师指导下使用 【药品名称】 通用名称:注射用伊米苷酶 商品名称:思而赞®;Cerezyme® 英文名称:Imiglucerase for Injection 汉语拼音:Zhusheyong Yimiganmei 【成份】 本品主要成份为伊米苷酶。

Cerezyme (imiglucerase) for injection is intended for intravenous use. It is supplied as a sterile, nonpyrogenic, white to off-white lyophilized powder for reconstitution with Sterile Water for Injection, USP.

注射用伊米苷酶，用于确诊患有导致下列一种或多种病症的Ⅰ型戈谢氏病（Gaucher disease）的儿童及成人患者的长期酶替代疗法：贫血；血小板减少；骨病；肝肿大或脾肿大。

伊米苷酶 （商品名：思而赞，英文名称：Cerezyme）是由赛诺菲研发1994年在美国上市，罕见病 戈谢病 注射剂特效药。 2009年开始，思而赞进入中国大陆。 一瓶思而赞是400单位。 戈谢病治疗时需终身注射“思而赞”，一支就要2万余元。

Cerezyme is a hydrolytic lysosomal glucocerebrosidase-specific enzyme indicated for treatment of adults and pediatric patients 2 years of age and older with Type 1 Gaucher disease that results in...

什么是 Cerezyme？ Cerezyme含有活性物质imiglucerase，用于治疗确诊为I型或Ⅲ 型戈谢病的患者，他们表现出该疾病的迹象，如：贫血（红细胞数量少）、容易出血（由于